Company / PP&E per Share
ANI Pharmaceuticals, Inc. PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$2.96
FY2025
5-year range
$2.45 / $4.18
FY2021-FY2025
Trend
-15.4%
vs FY2024
Sector context
#30 of 191
Health Care
What the data says
ANI Pharmaceuticals, Inc.'s pp&e per share of $2.96 is higher than 84% of companies in the Health Care sector (FY2025). PP&E per Share has fluctuated over the past 10 years, ranging from $0.95 in FY2016 to $4.18 in FY2021.
Based on SEC 10-K filings.
2.96 in FY2025 with a 5-year CAGR of -3.0%. Top quartile in the Health Care sector.
Improved from $2.45 to $2.96 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +3.6%
- 5-Year CAGR
- -3.0%
- 10-Year CAGR
- -
Sector benchmark
-86.8% below sector average
Key checks
Key Insights
- In FY2025, pp&e per share decreased 15.4% year-over-year.
- Ranks #30 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2021.
- Lowest pp&e per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.96 | -15.4% |
| FY2024 | $3.50 | +42.7% |
| FY2023 | $2.45 | -7.8% |
| FY2022 | $2.66 | -36.4% |
| FY2021 | $4.18 | +21.2% |
| FY2020 | $3.45 | -1.8% |
| FY2019 | $3.51 | +8.5% |
| FY2018 | $3.24 | +83.3% |
| FY2017 | $1.77 | +85.8% |
| FY2016 | $0.95 | -99.9% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026